These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15303561)

  • 1. Effective risk management programmes.
    Donawa M
    Med Device Technol; 2004 May; 15(4):28-30. PubMed ID: 15303561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is in the QSR/GMP?
    Bartoo G;
    IEEE Eng Med Biol Mag; 2004; 23(4):83-5. PubMed ID: 15508391
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating risk management into the CAPA process.
    Bills E; Tartal J
    Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
    [No Abstract]   [Full Text] [Related]  

  • 4. How to kick-start your CAPA process.
    Peterson K
    Biomed Instrum Technol; 2005; 39(1):55-9. PubMed ID: 15742850
    [No Abstract]   [Full Text] [Related]  

  • 5. European medical device regulation: a new era?
    Donawa M
    Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management.
    Bartoo G
    IEEE Eng Med Biol Mag; 2003; 22(4):166-70, 172. PubMed ID: 14515712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dilemma of reporting device-related adverse events.
    Donawa M
    Med Device Technol; 2003; 14(1):26-31. PubMed ID: 12974122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IVD directive: late-phase practicalities.
    Johnson P; Walker R
    Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
    [No Abstract]   [Full Text] [Related]  

  • 9. Beyond the US submisson process.
    Donawa M
    Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the European database.
    Donawa M
    Med Device Technol; 2001 Oct; 12(8):21-4. PubMed ID: 12938545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing new European vigilance procedures.
    Donawa M
    Med Device Technol; 2007; 18(7):34, 36-7. PubMed ID: 18075133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the revised electromagnetic compatibility standard.
    Bozec D; Hayes DJ
    Med Device Technol; 2004 Oct; 15(8):33-4, 36. PubMed ID: 16225272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the Medical Device Directive.
    Donawa M
    Med Device Technol; 2003 Mar; 14(2):20-3. PubMed ID: 12698694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the QSR/GMP, and why should you care?
    Bartoo G
    IEEE Eng Med Biol Mag; 2004; 23(2):98-9. PubMed ID: 15264479
    [No Abstract]   [Full Text] [Related]  

  • 15. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVD authorized representatives.
    Donawa ME
    Med Device Technol; 2003 May; 14(4):19-21. PubMed ID: 12774572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparing for more active market surveillance.
    Donawa M
    Med Device Technol; 2005 May; 16(4):30-3. PubMed ID: 15941197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing US and European device testing requirements.
    Donawa M
    Med Device Technol; 2008 Sep; 19(5):32, 34-7. PubMed ID: 18947148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluations clinical investigations under the amended Medical Device Directive.
    Dannhorn DR; Schwabedissen H
    Med Device Technol; 2008 Sep; 19(5):16-8, 20. PubMed ID: 18947145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposed amendments to the medical devices Directives.
    Donawa M
    Med Device Technol; 2006; 17(1):22-5. PubMed ID: 16483107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.